Fulcrum Therapeutics Q1 2026 Earnings Narrowing Losses as Pipeline Advances Tempest Therapeutics Inc TPST Q1 2026 Earnings Significant EPS Miss with No Revenue Stock Edges Up KODK Q1 2026 Earnings Narrowing Losses Amid Ongoing Restructuring TOI Q1 2026 Earnings Narrowing Losses Surprises Street Shares Edge Higher Satellogic SATL Q1 2026 Earnings EPS Misses Estimates by a Wide Margin Yet Stock Surges PTON Q1 2026 Earnings EPS Misses Estimates but Stock Rises on Subscriber Momentum